Recombinant human interferon-α14 for the treatment of canine allergic pruritic disease in eight dogs.

Background: Allergic pruritic diseases are increasingly common in dogs. This group of conditions hampers life quality as pruritus progressively interferes with normal behaviours. Therefore, new treatment modalities for canine allergic pruritic diseases are necessary.